Psychedelics for treatment resistant depression: are they game changers?
Kalfas M, Taylor RH, Tsapekos D, Young AH
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (6)
- PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW 2026-06-24 · Expand citations
- Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care 2026-05-11 · Expand citations
- With great power comes great responsibility: Promise and caution in the new psychedelic renaissance 2025-09-23 · Expand citations
- Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder 2025-09-04 · Expand citations
- Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-Position 2025-07-01 · Expand citations
- Psychedelics in the treatment of cluster headaches 2025-04-29 · Expand citations